| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.4M | +20.3% |
| Cost of Revenue | $15.3M | +24.2% |
| Gross Profit | $17.1M | +17.0% |
| R&D Expense | $9.4M | -3.9% |
| SG&A Expense | $17.8M | +3.8% |
| Operating Income | -$22.1M | +10.6% |
| Net Income | -$21.6M | +10.0% |
| EPS (Basic) | -$0.25 | +16.7% |
| EPS (Diluted) | -$0.25 | +16.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.4M | +9.9% |
| Accounts Receivable | $5.8M | +52.9% |
| Inventory | $9.6M | +14.8% |
| Current Assets | $33.8M | +28.0% |
| Total Assets | $52.3M | +11.8% |
| Current Liabilities | $22.4M | +3.5% |
| Total Liabilities | $33.5M | -5.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.7M | -61.1% |
| Investing Cash Flow | -$93K | -225.7% |
| Financing Cash Flow | $14.8M | +4870.7% |
| $13.5M |
| +121.7% |